Chewable calcium carbonate antacid tablet compositions

• US 5,629,013 A
• Filed: 04/28/1994
• Issued: 05/13/1997
• Est. Priority Date: 04/04/1991
• Status: Expired due to Term

• Current Assignee: The Procter & Gamble Company
• Original Assignee: The Procter & Gamble Company
• Inventors: Russell, Carmelita M., Upson, James G.
• Primary Examiner(s): Bawa, Raj
• Application Number:
  US08/234,510
• Time in Patent Office: 1,111 Days
• Field of Search: 424/439, 424/440, 424/441, 424/687, 424/464, 424/715, 514/819
• US Class Current: 424/441
• CPC Class Codes: A61K 9/0056 Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
• CPC Class Codes: A61K 9/2013 Organic compounds, e.g. phospholipids, fats

Abstract

Chewable antacid tablet compositions comprising calcium carbonate sweetened with aspartame, and preferably also saccharin wherein said composition is in a solid unit dose form to be ingested by chewing.

Claims

1. A chewable calcium carbonate-containing antacid tablet composition consisting essentially of:

(a) from about 1% to about 99% of calcium carbonate useful for treating upper gastrointestinal tract distress;

(b) from about 0.05% to about 1% of aspartame;

(c) from about 0.01% to about 1% of saccharin; and

(d) from about 1% to about 99% of at least one excipient comprising 3-1-methoxypropane 1,2-diol;

and wherein further said composition is in a solid unit dose form to be ingested by chewing.

2. A chewable calcium carbonate-containing antacid tablet composition consisting essentially of:

(a) from about 10% to about 60% of calcium carbonate;

(b) from about 0.05% to about 1% of aspartame;

(c) from about 0.01% to about 0.5% of saccharin; and

(d) from about 40% to about 90% of at least one excipient comprising 3-1-menthoxy propane 1,2-diol;

and wherein further said composition is in a solid unit dose form to be ingested by chewing.

3. A chewable calcium carbonate-containing antacid tablet composition according to claim 2 comprising from about 0.01% to about 0.50% of 3-1-menthoxy propane 1,2-diol.

4. A chewable calcium carbonate-containing antacid tablet composition consisting essentially of:

(a) from about 30% to about of 50% calcium carbonate;

(b) from about 0.1% to about 0.3% of aspartame;

(c) from about 0.05% to about 0.2% of sodium saccharin; and

(d) from about 50% to about 70% of at least one excipient comprising 3-1-menthoxy propane 1,2-diol;

and wherein further said composition is in a solid unit dose form to be ingested by chewing.

5. A chewable calcium carbonate-containing antacid tablet composition according to claim 4 comprising from about 0.04% to about 0.10% of 3-1-menthoxy propane 1,2-diol.